These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15006288)

  • 21. New technology and new initiatives in U.S. workplace testing.
    Walsh JM
    Forensic Sci Int; 2008 Jan; 174(2-3):120-4. PubMed ID: 17434275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug abuse and the rapid eye test.
    Hunt L
    Insight; 1994 Jun; 19(2):24-5. PubMed ID: 8006489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State of the art in hair analysis for detection of drug and alcohol abuse.
    Pragst F; Balikova MA
    Clin Chim Acta; 2006 Aug; 370(1-2):17-49. PubMed ID: 16624267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.
    Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Stoops WW; Rush CR
    Curr Top Behav Neurosci; 2018; 39():261-295. PubMed ID: 27272070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hair analysis for drug detection.
    Kintz P; Villain M; Cirimele V
    Ther Drug Monit; 2006 Jun; 28(3):442-6. PubMed ID: 16778731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.
    Griffiths RR; Johnson MW
    J Clin Psychiatry; 2005; 66 Suppl 9():31-41. PubMed ID: 16336040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Drug Evaluation Classification Program: using ocular and other signs to detect drug intoxication.
    Kosnoski EM; Yolton RL; Citek K; Hayes CE; Evans RB
    J Am Optom Assoc; 1998 Apr; 69(4):211-27. PubMed ID: 9585661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent abuse of other drugs.
    Greene JP; Ahrendt D; Stafford EM
    Adolesc Med Clin; 2006 Jun; 17(2):283-318. PubMed ID: 16814695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug abuse as a problem of impaired control: current approaches and findings.
    Fillmore MT
    Behav Cogn Neurosci Rev; 2003 Sep; 2(3):179-97. PubMed ID: 15006292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The substances and choices scale (SACS)--the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people.
    Christie G; Marsh R; Sheridan J; Wheeler A; Suaalii-Sauni T; Black S; Butler R
    Addiction; 2007 Sep; 102(9):1390-8. PubMed ID: 17645425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance abuse on the college campus.
    Rimsza ME; Moses KS
    Pediatr Clin North Am; 2005 Feb; 52(1):307-19, xii. PubMed ID: 15748936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.